Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
Mark J. Millan, Y. Agid, Martin Brüne, et al.
Nature Reviews Drug Discovery (2012) Vol. 11, Iss. 2, pp. 141-168
Closed Access | Times Cited: 1147

Showing 1-25 of 1147 citing articles:

Schizophrenia
René S. Kahn, Iris E. Sommer, Robin M. Murray, et al.
Nature Reviews Disease Primers (2015) Vol. 1, Iss. 1
Closed Access | Times Cited: 896
Is meditation associated with altered brain structure? A systematic review and meta-analysis of morphometric neuroimaging in meditation practitioners
Kieran C. R. Fox, Savannah Nijeboer, Matthew L. Dixon, et al.
Neuroscience & Biobehavioral Reviews (2014) Vol. 43, pp. 48-73
Closed Access | Times Cited: 710
Working memory improvement with non-invasive brain stimulation of the dorsolateral prefrontal cortex: A systematic review and meta-analysis
André R. Brunoni, Marie‐Anne Vanderhasselt
Brain and Cognition (2014) Vol. 86, pp. 1-9
Open Access | Times Cited: 620
Why primate models matter
Kimberley A. Phillips, Karen L. Bales, John P. Capitanio, et al.
American Journal of Primatology (2014) Vol. 76, Iss. 9, pp. 801-827
Open Access | Times Cited: 540
Altering the course of schizophrenia: progress and perspectives
Mark J. Millan, Annie Andrieux, George Bartzokis, et al.
Nature Reviews Drug Discovery (2016) Vol. 15, Iss. 7, pp. 485-515
Closed Access | Times Cited: 465
Psychosis as a transdiagnostic and extended phenotype in the general population
Jim van Os, Ulrich Reininghaus
World Psychiatry (2016) Vol. 15, Iss. 2, pp. 118-124
Open Access | Times Cited: 463
Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data
Connie Sanchéz, Karen E. Asin, Francesc Artigas
Pharmacology & Therapeutics (2014) Vol. 145, pp. 43-57
Open Access | Times Cited: 461
New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivity
Naomi Fineberg, Samuel R. Chamberlain, Anna E. Goudriaan, et al.
CNS Spectrums (2014) Vol. 19, Iss. 1, pp. 69-89
Open Access | Times Cited: 457
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Franz X. Vollenweider, Katrin H. Preller
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 11, pp. 611-624
Closed Access | Times Cited: 406
A computational psychiatry approach identifies how alpha-2A noradrenergic agonist Guanfacine affects feature-based reinforcement learning in the macaque
Seyed A. Hassani, Mariann Oemisch, Matthew Balcarras, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 370
Neuropsychological Impairments in Schizophrenia and Psychotic Bipolar Disorder: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Study
S. Kristian Hill, James L. Reilly, Richard S.E. Keefe, et al.
American Journal of Psychiatry (2013) Vol. 170, Iss. 11, pp. 1275-1284
Open Access | Times Cited: 345
Depression, anxiety-like behavior and memory impairment are associated with increased oxidative stress and inflammation in a rat model of social stress
Gaurav Patki, Naimesh Solanki, Fatin Atrooz, et al.
Brain Research (2013) Vol. 1539, pp. 73-86
Open Access | Times Cited: 344
Common Dysfunction of Large-Scale Neurocognitive Networks Across Psychiatric Disorders
Zhiqiang Sha, Tor D. Wager, Andrea Mechelli, et al.
Biological Psychiatry (2018) Vol. 85, Iss. 5, pp. 379-388
Open Access | Times Cited: 306
Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment
Mark J. Millan, K.C.F. Fone, Thomas Steckler, et al.
European Neuropsychopharmacology (2014) Vol. 24, Iss. 5, pp. 645-692
Open Access | Times Cited: 302
Computational Psychiatry
Xiao‐Jing Wang, John H. Krystal
Neuron (2014) Vol. 84, Iss. 3, pp. 638-654
Open Access | Times Cited: 296
GABAA Receptor Subtypes: Therapeutic Potential in Down Syndrome, Affective Disorders, Schizophrenia, and Autism
Uwe Rudolph, Hanns Möhler
The Annual Review of Pharmacology and Toxicology (2013) Vol. 54, Iss. 1, pp. 483-507
Open Access | Times Cited: 292
The clinical characterization of the adult patient with depression aimed at personalization of management
Mario Maj, Dan J. Stein, Gordon Parker, et al.
World Psychiatry (2020) Vol. 19, Iss. 3, pp. 269-293
Open Access | Times Cited: 287
<p>Cognitive impairment in depression: recent advances and novel treatments</p>
Giulia Perini, Matteo Cotta Ramusino, Elena Sinforiani, et al.
Neuropsychiatric Disease and Treatment (2019) Vol. Volume 15, pp. 1249-1258
Open Access | Times Cited: 286
Cognitive dysfunction in unipolar depression: Implications for treatment
Madhukar H. Trivedi, Tracy L. Greer
Journal of Affective Disorders (2013) Vol. 152-154, pp. 19-27
Closed Access | Times Cited: 269
The Potential of HDAC Inhibitors as Cognitive Enhancers
Johannes Gräff, Li‐Huei Tsai
The Annual Review of Pharmacology and Toxicology (2013) Vol. 53, Iss. 1, pp. 311-330
Closed Access | Times Cited: 267
Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
M. Lévy, Fabien Boulle, Harry W.M. Steinbusch, et al.
Psychopharmacology (2018) Vol. 235, Iss. 8, pp. 2195-2220
Open Access | Times Cited: 259
Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions
Roger S. McIntyre, Mohammad Alsuwaidan, Bernhard T. Baune, et al.
World Psychiatry (2023) Vol. 22, Iss. 3, pp. 394-412
Open Access | Times Cited: 256
Chronic Intranasal Oxytocin Causes Long-Term Impairments in Partner Preference Formation in Male Prairie Voles
Karen L. Bales, Allison M. Perkeybile, Olivia G. Conley, et al.
Biological Psychiatry (2012) Vol. 74, Iss. 3, pp. 180-188
Open Access | Times Cited: 251
Motivation and cognitive control in depression
Ivan Grahek, Amitai Shenhav, Sebastian Musslick, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 102, pp. 371-381
Open Access | Times Cited: 246
PTSD symptoms among health workers and public service providers during the COVID-19 outbreak
Sverre Urnes Johnson, Omid V. Ebrahimi, Asle Hoffart
PLoS ONE (2020) Vol. 15, Iss. 10, pp. e0241032-e0241032
Open Access | Times Cited: 246
Page 1 - Next Page

Scroll to top